By Zach Winnick ( April 2, 2012, 8:15 PM EDT) -- Illumina Inc.'s board of directors unanimously rejected a revised $6.5 billion hostile takeover bid from Roche Holding AG on Monday, saying the drugmaker's 15 percent increase over a $44.50-per-share offer from January still undervalues the gene-sequencing company....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.